sever
acut
respiratori
syndrom
coronaviru
associ
coronaviru
diseas
wreak
havoc
healthcar
system
global
potenti
spread
highli
infecti
viru
transmiss
lethal
influenza
reach
pandem
proport
left
mani
clinician
scrambl
provid
care
scarc
resourc
set
cur
treatment
immun
effect
therapi
candid
therapi
includ
antivir
remdesivir
antimalari
hydroxychloroquin
vaccin
moreov
learn
viru
begun
draw
noteworthi
conclus
regard
current
avail
ancillari
therapi
may
affect
natur
histori
infect
therapi
may
actual
avoid
certain
medic
like
ibuprofen
likewis
patient
angiotensinconvert
enzym
ace
inhibitor
angiotensin
receptor
blocker
arb
could
greater
risk
due
mechan
enter
cell
stand
reason
therapeut
act
counter
mechan
may
confer
protect
angiotensin
ang
ii
novel
vasopressor
agent
recent
approv
usa
europ
may
role
vasopressor
shock
well
known
role
confer
protect
patient
shock
perhap
without
unknown
must
explor
time
intern
crisi
level
critic
ill
attribut
recent
describ
recent
outbreak
china
approxim
patient
requir
icu
admiss
itali
preval
critic
ill
surpass
rate
seen
china
icu
admiss
requir
posit
case
hospit
patient
critic
ill
patient
typic
describ
older
comorbid
case
involv
young
healthi
patient
challeng
gener
patient
typic
admit
icu
day
ill
commonli
result
respiratori
failur
acut
respiratori
distress
syndrom
ard
less
common
respiratori
failur
septic
shock
may
occur
signific
portion
patient
associ
increas
mortal
case
seri
china
describ
incid
shock
cohort
hospit
patient
sever
diseas
incid
rose
reninangiotensinaldosteron
system
raa
may
tie
pathogenesi
viral
ill
tradit
raa
pathway
util
primarili
pulmonari
capillari
endotheli
enzym
convert
angi
angii
signific
lung
injuri
decreas
activ
pulmonari
capillari
endothelialbound
ace
initi
report
china
demonstr
approxim
patient
sever
ill
ard
increas
risk
low
function
notabl
inadequ
ace
function
independ
predictor
mortal
specif
viru
sarscoronaviru
receptor
util
cellular
proteas
enter
target
cell
fig
spike
protein
viral
surfac
shown
bind
time
affin
coronaviru
respons
sar
outbreak
higher
affin
may
explain
eas
humantohuman
transmiss
current
pandem
preclin
studi
novel
coronavirus
eg
highlight
degre
express
directli
correl
degre
infect
thu
strategi
decreas
express
may
attenu
impact
infect
endogen
mammalian
peptid
angii
hypothes
prevent
infect
multipl
way
first
normal
bind
degrad
hydrolysi
angiotensin
may
compet
receptor
fig
second
bind
angii
receptor
shown
caus
intern
downregul
map
kinas
pathway
vitro
anim
vivo
human
model
third
angii
shown
caus
receptordepend
destruct
ubiquitin
transport
lysosom
competit
inhibit
downregul
intern
degrad
may
decreas
degre
viral
infect
interf
host
cell
entri
viru
much
made
hypothet
risk
set
ace
inhibitor
arb
shown
multipl
investig
increas
express
activ
fact
sever
diseas
describ
patient
condit
known
associ
raa
blockad
therapi
hypertens
diabet
mellitu
howev
date
link
ace
inhibitor
arb
sever
ill
infect
pure
specul
american
colleg
cardiolog
european
societi
cardiolog
publish
statement
advis
discontinu
ace
inhibitor
arb
fig
effect
angiotensin
ii
raa
bind
angiotensin
hydrolyz
form
angiotensin
ii
bind
receptor
caus
releas
aldosteron
adren
gland
vasopressin
secret
hypothalamu
vasoconstrict
vasopressin
aldosteron
lead
increas
sodium
free
water
reabsorpt
kidney
lead
increas
mean
arteri
pressur
map
angiotensin
ii
metabol
ang
bind
gain
entri
host
cell
exogen
angiotensin
ii
also
bind
lead
competit
inhibit
receptor
addit
bind
angiotensin
ii
receptor
lead
intern
downregul
degrad
action
may
potenti
prevent
enter
cell
figur
creat
motifolio
toolkit
angiotensin
ii
sever
acut
respiratori
syndrom
coronaviru
angiotensinconvertingenzym
angiotensinconvertingenzym
h
water
na
sodium
support
map
angii
set
infect
seem
physiolog
ration
given
aforement
hypothes
tabl
due
larg
number
critic
ill
patient
angii
made
avail
itali
germani
unit
kingdom
compassion
use
despit
approv
european
medicin
agenc
yet
commerci
avail
europ
perhap
learn
import
lesson
patient
inform
effort
go
forward
instanc
angii
use
patient
shock
consid
earlier
cours
diseas
perhap
firstlin
vasopressor
final
controversi
evalu
modul
effect
angii
treatment
patient
without
shock
angii
use
describ
subpressor
dose
multipl
studi
shown
higher
level
map
may
harm
pandem
evolv
must
consid
form
therapi
may
flatten
curv
http
wwwflattenthecurvecom
physiolog
relationship
angiotensin
ii
persuas
given
enorm
situat
oblig
explor
therapi
potenti
avenu
treatment
tabl
inform
support
use
angiotensin
ii
diseas
increas
increas
infect
sar
decreas
express
decreas
infect
sar
util
enter
cell
like
patient
take
ace
inhibotor
arb
increas
express
exogen
angiotensin
ii
decreas
express
patient
hypertens
high
risk
sever
covid
infect
death
hypothesi
exogen
angiotensin
ii
via
reduct
express
vasculatur
heart
may
decreas
viral
propag
thu
improv
outcom
